Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients
Conditions: Dyslipidemias; Statin Adverse Reaction; Cardiovascular Diseases; Lipid Metabolism Disorders Interventions: Drug: Lipid-lowering therapy combination with PCSK9 inhibitors, bempedoic acid and ezetimibe; Drug: Lipid-lowering therapy combination with PCSK9 inhibitors and ezetimibe Sponsors: University of Salerno Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Research | Statin Therapy | Vytorin | Zetia